Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03586648
Other study ID # CR-6267
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 14, 2018
Est. completion date August 20, 2018

Study information

Verified date April 2020
Source Johnson & Johnson Vision Care, Inc.
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This is a single-masked, randomized-controlled, dispensing clinical trial. A total of approximately 60 eligible hyperopic subjects will be targeted to complete this study.


Recruitment information / eligibility

Status Completed
Enrollment 71
Est. completion date August 20, 2018
Est. primary completion date August 20, 2018
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 40 Years to 70 Years
Eligibility Inclusion Criteria:

- Potential subjects must satisfy all the following criteria to be enrolled in the study:

1. The subject must read, understand, and sign the STATEMENT OF INFORMED CONSENT and receive a fully executed copy of the form.

2. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.

3. The subject must be between 40 and 70 years of age (inclusive).

4. The subject's distance spherical equivalent refraction must be in the range of -1.25 D to -3.75 D in each eye.

5. The subject's refractive cylinder must be =0.75 D in each eye.

6. The subject's ADD power must be in the range of +0.75 D to +2.50 D.

7. The subject must have distance best corrected visual acuity of 20/20-3 or better in each eye.

8. Subjects must own a wearable pair of spectacles if required for their distance vision.

9. The subject must be an adapted soft contact lens wearer in both eyes (i.e. worn lenses a minimum of 2 days per week for at least 8 hours per wear day, for 1 month of more duration).

10. The subject must either already be wearing a presbyopic contact lens correction (e.g., reading spectacles over contact lenses, multifocal or monovision contact lenses, etc.) or if not respond positively to at least one symptom on the "Presbyopic Symptoms Questionnaire".

Exclusion Criteria:

- Potential subjects who meet any of the following criteria will be excluded from participating in the study:

1. Currently pregnant or lactating.

2. Any active or ongoing ocular or systemic allergies that may interfere with contact lens wear.

3. Any active or ongoing systemic disease, autoimmune disease, or use of medication, which may interfere with contact lens wear. This may include, but not be limited to, diabetes, hyperthyroidism, Sjögren's syndrome, xerophthalmia, acne rosacea, Stevens-Johnson syndrome, and immunosuppressive diseases or any infectious diseases (e.g. hepatitis, tuberculosis).

4. Clinically significant (Grade 3 or 4) corneal edema, corneal vascularization, corneal staining, tarsal abnormalities or bulbar injection, or any other corneal or ocular abnormalities which would contraindicate contact lens wear.

5. Entropion, ectropion, extrusions, chalazia, recurrent styes, dry eye, glaucoma, history of recurrent corneal erosions.

6. Any previous, or planned, ocular or intraocular surgery (e.g. radial keratotomy, PRK, LASIK, lid procedures, cataract surgery, retinal surgery, etc.).

7. A history of amblyopia, strabismus or binocular vision abnormality.

8. Any current ocular infection or inflammation.

9. Any current ocular abnormality that may interfere with contact lens wear.

10. Use of any of the following oral medications within 1 week prior to enrollment: oral retinoid isotretinoin (e.g. Accutane), oral tetracyclines, topical scopolamine, oral antihistamines (e.g., Chlor-Trimeton, and Benadryl), systemic steroids.

11. Use of any ocular medication, with the exception of rewetting drops.

12. History of herpetic keratitis.

13. Participation in any contact lens or lens care product clinical trial within 30 days prior to study enrollment.

14. Employee or immediate family member of an employee of clinical site (e.g., Investigator, Coordinator, Technician).

15. Any known hypersensitivity or allergic reaction to Optifree®Replenish® multipurpose care solution or Eye-Cept® rewetting drop solution.

Study Design


Related Conditions & MeSH terms


Intervention

Device:
senofilcon A Multifocal
TEST Lens
senofilcon A Sphere
TEST Lens Sphere
etafilcon A Multifocal
CONTROL Lens
etafilcon A Sphere
CONTROL Lens Sphere

Locations

Country Name City State
United States Western Reserve Vision Care Beechwood Ohio
United States Procare Vision Center Granville Ohio
United States Dr. James E. Weber Jacksonville Florida
United States Maitland Vision Center Maitland Florida
United States Wayne Golden, OD Sarasota Florida
United States Golden Optometric Group Whittier California

Sponsors (1)

Lead Sponsor Collaborator
Johnson & Johnson Vision Care, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Vision Scores Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. 2-Week Follow-up
Primary Vision Scores Comparison Between Test and Control Overall quality of vision was assessed using the Contact Lens User Experience™ (CLUE) questionnaire. CLUE is a validated patient-reported outcomes (PRO) questionnaire to assess patient-experience attributes of soft contact lenses (comfort, vision, handling, and packaging) in a contact-lens wearing population in the US, ages 18-65. Derived CLUE scores using Item Response Theory (IRT) follow a normal distribution with a population average score of 60 (SD 20), where higher scores indicate a more favorable/positive response with a range of 0-120. 2-Week Follow-up
See also
  Status Clinical Trial Phase
Completed NCT06019806 - Effects of Forward Head Posture Correction on Visual Acuity in Low Level Visually Impaired University Students N/A
Completed NCT04567186 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Hyperopic Population N/A
Completed NCT02568254 - Evaluation of Three Daily Disposable Contact Lenses N/A
Completed NCT01951703 - Senofilcon A Investigational Manufacturing Process N/A
Terminated NCT00637468 - EAGLE - Multicenter Study of the European Assessment Group for Lysis in the Eye Phase 3
Recruiting NCT04632901 - A New Parameter for the Assessment of Distance Visual Capacity: the Critical Visual Acuity (CVA)
Active, not recruiting NCT03747601 - Temporal Interference Brain Stimulation N/A
Completed NCT06131476 - Clinical Investigation of Visual Acuity in Contact Lens Wearers After Instillation of a Lipid- Based Lubricating Eye Drop Phase 1
Recruiting NCT05414565 - Post-Market Study of Alcon Intraocular Lenses
Completed NCT05056870 - Clinical Evaluation of Spherical Soft Contact Lenses, Toric Soft Contact Lenses and Spectacles in Low Astigmats N/A
Completed NCT04615507 - Evaluation of a Daily Disposable Novel Multifocal Contact Lens in a Myopic Population; Part 2 N/A
Completed NCT05099380 - Validation of Senofilcon A With New UV / HEV Filter N/A
Completed NCT03713281 - Evaluation of a Toric Multifocal Contact Lens Manufactured in Etafilcon Material in a Low ADD Hyperopic Population
Completed NCT05582304 - Role of Glare and Spectral Filtering on Contrast Sensitivity: A Pilot Study N/A
Completed NCT03742271 - Evaluation of Senofilcon A With New UV-blocker on a Neophyte Population N/A
Completed NCT04995055 - Evaluation of Multifocal Contact Lens Designs With and Without an HEV Blocker on Visual Function N/A
Completed NCT05554640 - Clinical Performance of Two Daily Disposable Silicone Hydrogel Contact Lenses N/A
Completed NCT01926704 - MTF Image Modifications N/A
Completed NCT04649606 - Dynamic Characterisation of Meibomian Gland Structure
Completed NCT05101252 - Comparison of a Daily Disposable Multifocal Contact Lens to a Marketed Product N/A